Defibrillation testing and early neurologic outcome

Area of Science:

• Cardiology
• Neurology

Background:

• Implantable cardioverter-defibrillator (ICD) implantation includes ventricular defibrillation testing (DFT).
• Repeated ventricular fibrillation (VF) induction during DFT may pose a risk of neurological damage due to cerebral ischemia.

Purpose of the Study:

• To evaluate the impact of limited VF induction during ICD implantation on cognitive and neurological functions.
• To assess serum neuron-specific enolase (NSE) levels as a biomarker for cerebral injury post-ICD implantation.

Main Methods:

• 16 patients undergoing initial ICD implantation were assessed.
• Neurological examinations and cognitive tests were performed pre- and post-procedure.
• Serum NSE levels were measured at multiple time points: before, during, and up to 48 hours after implantation.

Main Results:

• No significant differences were found in neurological or cognitive assessments between pre- and post-implantation evaluations.
• Serum NSE levels remained unchanged from baseline throughout the 48-hour observation period.
• Patients reported no new neurological symptoms, and examinations revealed no new abnormalities.

Conclusions:

• Limited induction of VF for defibrillation safety margin testing during ICD implantation appears safe.
• Brief periods of cerebral circulatory arrest associated with ICD procedures do not lead to detectable permanent neurological injury.
• Further research is recommended to confirm these findings in larger cohorts.